Mehdi Gholam-Rezaee, PhD
- 2Articles
- 7.8KReads
- 2015–2019Active
- 17Collaborators
- 170Citations
About
Mehdi Gholam-Rezaee, PhD, has published research on metabolic effects related to psychotropic medication, focusing on lipid disturbances and weight changes in patients with schizophrenia and schizoaffective disorders. The work includes studies on clinical factors influencing plasma lipid worsening in adolescents treated with second-generation antipsychotics and early weight changes as predictors of long-term weight gain during psychotropic drug treatment. Collaborators frequently include Anne-Emmanuelle Ambresin, Aurélie Delacrétaz, Chin B. Eap, Frederik Vandenberghe, and Philippe Conus.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
